Systemic remifentanil for labor analgesia.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 19923522.
- Also identified by DOI 10.1213/ANE.0b013e3181c03e0c.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
There is a need for safe, effective, and easy-to-administer systemic analgesia that ideally has rapid onset and offset, matches the time course of uterine contractions, and does not compromise the fetus. Although neuraxial blockade is the "gold standard" for labor analgesia, systemic analgesia is useful in those cases in which neuraxial analgesia is contraindicated, refused or simply not needed by the parturient, or when skilled anesthesia providers are not available. Because of its unique pharmacologic properties, remifentanil has been investigated, and is used clinically, to provide IV labor analgesia. In this focused review, we summarize the efficacy of remifentanil as a labor analgesic and review the current literature regarding its dose, mode of delivery, safety for the mother and fetus/neonate, as well as the scope for future research.
Medical subject headings
- Analgesia, Obstetrical
- Analgesia, Patient-Controlled
- Analgesics, Opioid
- Labor Pain
- Piperidines